Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial

Publication | Open Access

DOI Full Paper Access

Citations

References

2021

Year

Benoît Tessoulin, David Chiron, Catherine Thiéblemont, Lucie Obéric, Kamal Bouadballah, Emmanuel Gyan, Gandhi Damaj, Vincent Ribrag, Rémy Gressin, Pierre Feugier,

Bone Marrow Transplantation

Hematological MalignancyMantle-cell LymphomaLymphoid NeoplasiaLyma Prospective TrialTransplantationMedicineHematologyAutologous TransplantationCell TransplantationImmunotherapyOncologyRadiation OncologyHealth Sciences